Skip to main content
Clinical Trials/NCT03961425
NCT03961425CompletedNot Applicable

Cardia Carbonaid VS Standard Cannula VS NO CO2 Approach: Impact on Time to Complete Deairing and Clinical Neurological Events; a Randomized Prospective Study.

Cardiochirurgia E.H.1 site in 1 country180 target enrollmentStarted: June 1, 2019Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
180
Locations
1
Primary Endpoint
Time to Complete Deairing

Study Overview

Brief Summary

Prospective Randomized study comparing three strategy of deairing (NO CO2 insufflation, CO2 insufflation with non specific cannula, CO2 insufflation with commercial dedicated diffuser) as regarding Time to Complete Deairing measured from declamping via TEE Echo and Neurological Events at Wake Up

Detailed Description

The impact of air bubbles into the cerebral circulation after open heart surgery has been a topic of discussion since the introduction of the heart-lung machine, and flooding the surgical field with CO2, which is heavier than Azote and Oxygen but over ten times more soluble seems a promising technique to minimize the presence of air microemboli. However very few studies have been conducted to ascertain what is the most efficient way to administer this treatment, or even of this treatment really impacts deairing time and clinical neurological events.

This study aims at comparing the use of CO2 (administered in two different ways: a simple cannula, which might be prone to emulsioning air and CO2 not reaching a complete CO2 saturation and a specific commercial diffuser which states promises complete filed saturation) to the no-CO2 standard approach.

The primary end point will be Time to Complete deairing as measured by intraoperative transesophageal echo while the secondary end point will be the incidence of clinical neurological events the day after the operation.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Factorial
Primary Purpose
Prevention
Masking
Single (Outcomes Assessor)

Masking Description

Clinical Outcomes are assessed by ICU physicians and the intraoperative strategy is not disclosed

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Isolated, Elective Aortic Valve Replacement or combined AVR and CABG

Exclusion Criteria

  • •any other kind of operation

Arms & Interventions

NO CO2

Active Comparator

Traditional De Airing maneuver

Intervention: NO CO2 (Behavioral)

CO2 Cannula

Active Comparator

CO2 at 8 l/min since 2 minutes before aortic cross clamp delivered by non specific needle cannula

Intervention: CO2 Cannula (Device)

CO2 Cardia

Active Comparator

CO2 at 8 l/min since 2 minutes before aortic cross clamp delivered by commercial diffuser Cardia

Intervention: CO2 Cardia (Device)

Outcomes

Primary Outcomes

Time to Complete Deairing

Time Frame: Intraoperative

Number of seconds since Declamping until no more air bubbles are visible on TEE Echo

Secondary Outcomes

  • Neurological Events at Wake Up(The day after operation)

Investigators

Sponsor
Cardiochirurgia E.H.
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Luca Weltert

Professor of Biostatistics, Heart Surgeon

Cardiochirurgia E.H.

Study Sites (1)

Loading locations...

Similar Trials

CO2 Field Saturating Alternative... | Clinical Trial